跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DEXTROSE 5% AND SODIUM CHLORIDE 0.45% INJECTION USP - HSA Drug Approval Details
Approvals
/
HSA
/
DEXTROSE 5% AND SODIUM CHLORIDE 0.45% INJECTION USP
Approved
THERAPEUTIC
DEXTROSE 5% AND SODIUM CHLORIDE 0.45% INJECTION USP
BAXTER HEALTHCARE CORPORATION, NORTH COVE PLANT - UNITED STATESBAXTER HEALTHCARE PHILIPPINES, INC. (PHILIPPINES)
🇸🇬 Health Sciences Authority
Approval Date
Apr 8, 1991
Approval ID
dbcadf8b2c517589
Company
BAXTER HEALTHCARE CORPORATION, NORTH COVE PLANT - UNITED STATESBAXTER HEALTHCARE PHILIPPINES, INC. (PHILIPPINES)
Type
Therapeutic
Approval Details
Approval Id
dbcadf8b2c517589
Drug Name
DEXTROSE 5% AND SODIUM CHLORIDE 0.45% INJECTION USP
Product Name
DEXTROSE 5% AND SODIUM CHLORIDE 0.45% INJECTION USP
Approval Number
SIN05729P
Approval Date
1991-04-08
Registrant
BAXTER HEALTHCARE (ASIA) PTE LTD
Licence Holder
BAXTER HEALTHCARE (ASIA) PTE LTD
Drug Type
Therapeutic
Forensic Classification
GENERAL SALE LIST
Dosage Form
INJECTION
Route Of Administration
INTRAVENOUS
Atc Code
B05XA03
Atc Item Name
sodium chloride
Pharma Manufacturer Name
BAXTER HEALTHCARE (ASIA) PTE LTD
Company Detail Path
/organization/baxter-healthcare-asia-pte-ltd
Active Ingredients
SODIUM CHLORIDE
450 mg/100 ml
DEXTROSE ANHYDROUS 4.5 g/100 ml EQV DEXTROSE HYDROUS
5 g/100 ml
DEXTROSE ANHYDROUS 4.5 G/100 ML EQV DEXTROSE HYDROUS
5 G/100 ML
SODIUM CHLORIDE
450 MG/100 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 8, 1991
Approval ID
dbcadf8b2c517589
Type
Therapeutic
Back to HSA Approvals
